These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 3743937
1. [Electrophysiologic effects and clinical efficacy of propafenone in pediatric patients with paroxysmal supraventricular reentrant tachycardia]. Musto B, D'Onofrio A, Musto A, Cavallaro C, Marsico F. G Ital Cardiol; 1986 Apr; 16(4):336-43. PubMed ID: 3743937 [Abstract] [Full Text] [Related]
5. Effects of propafenone on induction and maintenance of atrioventricular nodal reentrant tachycardia. Garcia-Civera R, Sanjuan R, Morell S, Ferrero JA, Miralles L, Llavador J, Lopez-Merino V. Pacing Clin Electrophysiol; 1984 Jul; 7(4):649-55. PubMed ID: 6205364 [Abstract] [Full Text] [Related]
6. Electrophysiological effects and clinical efficacy of propafenone in children with recurrent paroxysmal supraventricular tachycardia. Musto B, D'Onofrio A, Cavallaro C, Musto A. Circulation; 1988 Oct; 78(4):863-9. PubMed ID: 3168194 [Abstract] [Full Text] [Related]
7. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia. Gambhir DS, Bhargava M, Arora R, Khalilullah M. Indian Heart J; 1995 Oct; 47(3):237-43. PubMed ID: 7558090 [Abstract] [Full Text] [Related]
9. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia. Gambhir DS, Bhargava M, Nair M, Arora R, Khalilullah M. Indian Heart J; 1996 Oct; 48(2):133-7. PubMed ID: 8682552 [Abstract] [Full Text] [Related]
13. Ethmozin. I. Effects of intravenous drug administration on paroxysmal supraventricular tachycardia in the ventricular preexcitation syndrome. Chazov EI, Shugushev KK, Rosenshtraukh LV. Am Heart J; 1984 Sep; 108(3 Pt 1):475-82. PubMed ID: 6382988 [Abstract] [Full Text] [Related]
16. [Electrophysiologic effects of diprafenone in supraventricular and ventricular tachycardia]. Manz M, Beermann J, Gerckens U, Lüderitz B. Z Kardiol; 1986 Dec; 75(12):757-63. PubMed ID: 3825226 [Abstract] [Full Text] [Related]
17. Differential effects of intravenous magnesium on atrioventricular node conduction in supraventricular tachycardia. Stiles MK, Sanders P, Disney P, Brooks A, John B, Lau DH, Shashidhar, Wilson L, Mackenzie L, Young GD. Am J Cardiol; 2007 Oct 15; 100(8):1249-53. PubMed ID: 17920366 [Abstract] [Full Text] [Related]
18. [The treatment of arrhythmias in infants and children using propafenone]. Dressler F, Grävinghoff L, Grütte E, Jüngst BK, Liersch R, Nomayo H, Puls I, Rautenburg HW, Schmaltz A, Schumacher G. Monatsschr Kinderheilkd; 1985 Mar 15; 133(3):154-7. PubMed ID: 4010670 [Abstract] [Full Text] [Related]
19. [The study of acute clinical electrophysiological effects of propafenone on paroxysmal supraventricular tachycardia using transesophageal atrial pacing technique]. Li Q, Wang Z, Peng D. Hunan Yi Ke Da Xue Xue Bao; 1997 Mar 15; 22(2):123-6. PubMed ID: 9868052 [Abstract] [Full Text] [Related]
20. Effect of propafenone in the Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up. Breithardt G, Borggrefe M, Wiebringhaus E, Seipel L. Am J Cardiol; 1984 Nov 14; 54(9):29D-39D. PubMed ID: 6496367 [Abstract] [Full Text] [Related] Page: [Next] [New Search]